Molecular Classification of Triple Negative Breast Cancer and the Emergence of Targeted Therapies
Elizabeth Sakach, Ruth O’Regan, Jane Meisel, Xiaoxian Li
Topics & Concepts
Triple-negative breast cancerMedicineBreast cancerTargeted therapyOncologyBiomarkerImmunotherapyCancerClinical trialInternal medicineChemistryBiochemistryPARP inhibition in cancer therapyAdvanced Breast Cancer TherapiesCancer Genomics and Diagnostics